Equity | Sector Specific - Pharma
3Y Returns
20.39%
Min SIP
₹100
Min Lumpsum
₹5000
Expense Ratio
2.51%
Fund Size
₹519 Cr
Inception Date
28-Dec-15
Fund Manager
Meeta Shetty
Exit Load
0.25% on or before 30D.
Market Risk / Risk Taken Compared to Benchmark
Fund Size
SIP Returns
Risk Adjusted Returns
Extra Returns Over Benchmark
Returns Consistency
Performance Against Inflation
Overall Fund Zi Tag
Asset Allocation
Equity
98.59%
Debt & Others
1.41%
Market Cap Allocation
Large Cap
52.67%
Mid Cap
26.65%
Small Cap
19.83%
Other Cap
0.85%
Investment Objective
Investment Objective Of The Scheme Is To Provide Long Term Capital Appreciation By Investing Predominantly In Equity/Equity Related Instruments Of The Companies In The Pharma&Healthcare Sectors In India. However, There Is No Assurance Or Guarantee That The Investment Objective Of The Scheme Will Be Achieved. The Scheme Does Not Assure Or Guarantee Any Returns.
Fund House Detail
AMC Name
Tata Asset Management Limited
Address
1903, B Wing, Parinee Crescenzo, G Block,Bandra Kurla Complex, Bandra East,Mumbai - 400 051
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Plan Growth
1Y
62.96%
3Y
23.36%
5Y
34.21%
Sbi Healthcare Opportunities Fund Direct Growth
1Y
53.12%
3Y
22.99%
5Y
32.61%
Dsp Healthcare Fund - Direct - Growth
1Y
57.79%
3Y
22.23%
5Y
35.05%
Tata India Pharma And Healthcare Fund Direct Plan Growth
1Y
57.77%
3Y
22.18%
5Y
31.17%
Uti Healthcare Fund - Direct Growth Plan
1Y
59.03%
3Y
20.48%
5Y
31.83%
Nippon India Pharma Fund Direct Plan Growth Plan - Growth Option Growth
1Y
51%
3Y
20.12%
5Y
31.42%
Mirae Asset Healthcare Fund - Direct Plan - Growth
1Y
54.42%
3Y
19.75%
5Y
33.59%
Aditya Birla Sunlife Life Pharma And Healthcare Fund Direct Growth
1Y
56.09%
3Y
19.58%
5Y
28.61%
Woc Pharma And Healthcare Fund - Direct Plan - Growth
1Y
NA
3Y
NA
5Y
NA
Hdfc Pharma And Healthcare Fund - Growth Option - Direct Plan
1Y
63.79%
3Y
NA
5Y
NA
Quant Healthcare Fund - Direct Plan Growth - Growth
1Y
64.15%
3Y
NA
5Y
NA
Kotak Healthcare Fund-Direct Plan-Growth
1Y
NA
3Y
NA
5Y
NA
Iti Pharma And Healthcare Fund - Direct Plan - Growth
1Y
57.22%
3Y
NA
5Y
NA
Lic Healthcare Fund - Direct Plan - Growth
1Y
NA
3Y
-0.5%
5Y
15.61%
BSE Member code: 58371
Wealthzi Investment Advisers (A division of Lime Internet Private Limited)
[CIN: U74999DL2017PTC310507] [PAN: AADCL2103M] [GSTIN: 07AADCL2103M1ZP]
[SEBI Registered Name: Lime Internet Private Limited] [SEBI RIA Registration No: INA000018133] [BASL Member ID: 2014] [Type of Registration: Non-Individual] [Validity of Registration: Perpetual] [Registered Address: Flat No. 603, 6th Floor, Kanchenjunga Building, 18 Barakhamba Road, New Delhi - 110001] [Principal Officer: Jyoti Prakash Nayak, Email: [email protected]] [Compliance Officer: Harshit Singh, Email: [email protected]] [Grievance Officer: Sanjeev Johari, Email: [email protected]]
[SEBI Regional Office Address: Securities and Exchange Board of India, NBCC Complex, Office Tower-1, 8th Floor, Plate B, East Kidwai Nagar, New Delhi - 110023, Ph: 011-69012998, Email: [email protected]]
Disclaimers:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI, membership of BASL and certification from National Institute of Securities Markets (NISM) in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
The information is only for consumption by the client and such material should not be redistributed.